Baicalin Inhibits Lipopolysaccharide-Induced Inflammation Through Signaling NF-κB Pathway in HBE16 Airway Epithelial Cells

Inflammation

Volumn 38, Issue 4, 2015, Pages 1493-1501

  Dong, Shou jin ^a   Zhong, Yun qing ^b   Lu, Wen ting ^c   Li, Guan hong ^a   Jiang, Hong li ^a   Mao, Bing ^a  

^a SICHUAN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

^c Department of Geratology Sichuan Hospital of Integrated Traditional Chinese and Western Medicine   (China)

Author keywords

airway epithelial cells; baicalin; inflammation; intervention effect and mechanism; NF B

Indexed keywords

ANTIINFLAMMATORY AGENT; BAICALIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; FLAVONOID;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CYTOKINE RELEASE; DOWN REGULATION; DRUG STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HBE16 CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; LIPOPOLYSACCHARIDE-INDUCED AIRWAY INFLAMMATION; LUNG ALVEOLUS CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFLAMMATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; CYTOLOGY; DRUG EFFECTS; INFLAMMATION; METABOLISM; PHYSIOLOGY; RESPIRATORY TRACT MUCOSA; SCUTELLARIA;

SCUTELLARIA BAICALENSIS;

FLAVONOIDS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; NF-KAPPA B; RESPIRATORY MUCOSA; SCUTELLARIA; SIGNAL TRANSDUCTION;

EID: 84937253664     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-015-0124-2     Document Type: Article

References (25)

1. Yang, J., X. Yang, and M. Li. 2012. Baicalin, a natural compound, promotes regulatory T cell differentiation. BMC Complementary and Alternative Medicine 12: 64.
2. Xiao, J.R., C.W. Do, and C.H. To. 2014. Potential therapeutic effects of baicalein, baicalin, and wogonin in ocular disorders. Journal of Ocular Pharmacology and Therapeutics 30(8): 605–614.
3. Lee W, Ku SK, Bae JS. Anti-inflammatory effects of baicalein, baicalein, and wogonin in vitro and in vivo. Inflammation 2014 Sep 24.[Epub ahead of print]
4. Ding Y, Dou J, Teng Z, et al. Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase. Archives of Virology 2014 Jul 31.[Epub ahead of print]
5. Sethi, S. 2010. Infection as a comorbidity of COPD. European Respiratory Journal 35: 1209–1215.
6. Henes, J., M.A. Schmit, J.C. Morote-Garcia, et al. 2009. Inflammation-associated repression of vasodilator-stimulated phosphoprotein (VASP) reduces alveolar-capillary barrier function during acute lung injury. FASEB Journal 23: 4244–4255.
7. Brown, J., H. Wang, G.N. Hajishengallis, et al. 2011. TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk. Journal of Dental Research 90(4): 417–427.
8. McGettrick, A.F., and L.A. O'Neill. 2010. Regulators of TLR4 signaling by endotoxins. Subcellular Biochemistry 53: 153–171.
9. Peter, J.B. 2009. The cytokine network in chronic obstructive pulmonary disease. American Journal of Respiratory Cell and Molecular Biology 41: 631–638.
10. Brusselle, G.G., S. Provoost, K.R. Bracke, et al. 2014. Inflammasomes in respiratory disease: from bench to bedside. Chest 145(5): 1121–1133.
11. Dong, S.J., Y.Q. Zhong, K. Yang, et al. 2013. Intervention effect and dose-dependent response of Tanreqing injection on airway inflammation in lipopolysaccharide-induced rats. Journal of Traditional Chinese Medicine 33(4): 505–512.
12. Krakauer, T., B.Q. Li, and H.A. Young. 2001. The flavonoid baicalin inhibits superantigen-induced inflammatory cytokines and chemokines. FEBS Letters 500: 52–55.
13. Tsai, D.S., Y.S. Chang, T.C. Li, et al. 2014. Prescription pattern of Chinese herbal products for hypertension in Taiwan: a population-based study. Journal of Ethnopharmacology 155(3): 1534–1540.
14. Moghaddam, E., B.T. Teoh, S.S. Sam, et al. 2014. Baicalin, a metabolite of baicalein with antiviral activity against dengue virus. Science Reports 4: 54–52.
15. Tu, X.K., W.Z. Yang, S.S. Shi, Y. Chen, C.H. Wang, C.M. Chen, and Z. Chen. 2011. Baicalin inhibits TLR2/4 signaling pathway in rat brain following permanent cerebral ischemia. Inflammation 34: 463–470.
16. Julie, B., R. Lucie, N. Leila, et al. 2010. Loss of cystic fibrosis transmembrane conductance regulator function enhances activation of p38 and Erk/MAPKs, increasing interleukin-6 synthesis in airway epithelial cells exposed to pseudomonas aeruginosa. Journal of Biological Chemistry 285(29): 22299–22307.
17. Zhao, Y., Y. Xu, Y. Li, et al. 2013. NF-κB-mediated inflammation leading to EMT via miR-200c is involved in cell transformation induced by cigarette smoke extract. Toxicological Sciences 135(2): 265–276.
18. Chen, X.S., and G.S. Qian. 2011. The signaling pathways of SIGIRR and TLRs. Sichuan Yi Xue 32(3): 428–430.
19. Cui, L., L. Feng, Z.H. Zhang, et al. 2014. The anti-inflammation effect of baicalin on experimental colitis through inhibiting TLR4/NF-κB pathway activation. International Immunology 23: 294–303.
20. Sender, V., and C. Stamme. 2014. Lung cell-specific modulation of LPS-induced TLR4 receptor and adaptor localization. Communicative & Integrative Biology 7: e29053.
21. Lucas, K., and M. Maes. 2013. Role of the toll like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway. Molecular Neurodegeneration 48(1): 190–204.
22. Jang, J., J.H. Ha, S.I. Chung, et al. 2014. Β-catenin regulates NF-κB activity and inflammatory cytokine expression in bronchial epithelial cells treated with lipopolysaccharide. International Journal of Molecular Medicine 34(2): 632–638.
23. Schwingshackl, A., B. Teng, M. Ghosh, et al. 2013. Regulation of interleukin-6 secretion by the two-pore-domain potassium channel Trek-1 in alveolar epithelial cells. American Journal of Physiology - Lung Cellular and Molecular Physiology 304(4): L276–286.
24. Shaw, Debbie. 2010. Toxicological risks of Chinese herbs. Planta Medica 76: 2012–2018.
25. Li M, Shi A, Pang H, et al. Safety, tolerability, and pharmacokinetics of a single ascending dose of baicalin chewable tablets in healthy subjects. Journal of Ethnopharmacology 2014; Pii: S0378-8741(14)00625-4.